SS&C Intralinks Success Stories
We’ve helped clients in nearly every country and industry throughout the world with secure innovative, productivity-driving solutions for high-value M&A, debt capital markets and banking transactions.
Here are just a few of our recent success stories. We’d love to add your brand to our hall of fame.
¥1.435 billion
Zhuhai Abax Fund is a venture fund managed by Abax Global Capital. The fund invests in a diversified range of industries in China.
$62.1 million
Zeal Capital Partners I seeks investment into high growth early stage financial services, fintech, and education companies.
$300 million
Yun Qi Partners III makes seed through series A investments in mobile internet, smart devices, and internet finance sectors.
$4 billion
Whitehorse Liquidity Partners IV follows a similar strategy to its predecessors, by acquiring a range of fund interests on the secondary market and targeting preferred equity investments.
$850 million
VMG Partners V invests in entrepreneurial early and late stage consumer focused companies across the US.
$825 million
Vida Ventures III is a fund managed by Vida Ventures. The fund invests in healthcare, biotechnology, and pharmaceuticals.
$817 million
True Wind Fund II is a buyout fund that focuses on investing in the US technology sector.
£$275 million
True Capital seeks to invest in UK-headquartered, lower-mid market businesses operating in the consumer products and services sector.
$270 million
Town Hall Ventures II applies a stage agnostic approach to investing in health care technology and services businesses across the United States.
STIC Global Innovative Growth Fund is a private growth fund managed by STIC Investments. The sector-agnostic fund plans to take minor stakes in promising sectors.
$10 billion
Starwood Distressed Opportunity Fund XII pursues an opportunistic real estate strategy across Europe, the United States, Asia and Australia
€472 million
Sofinnova Capital X is a venture capital fund investing into in early-stage healthcare companies in the biopharmaceutical and medical device industries in Europe.
$600 million
SkyKnight Capital Fund III is a mezzanine fund managed by SkyKnight Capital that invests in minority and "small majority" businesses, focuses on healthcare, insurance and tech enabled services.
€225 million
Singular is an early stage fund investing in European companies operating within a diversified range of sectors..
$240 million
The Siguler Guff Global Emerging Markets Co-Investment Fund will seek to build a diversified portfolio of investments in leading companies that are based in or utilize talents and expertise in the emerging markets.
$213 million
Shore Capital Business Services Partners Fund I is a buyout fund that focuses on business services industries across the US..
$300 million
Ronin Fund I invests in the industrial, consumer and TMT sectors throughout North America. The fund is managed by Ronin Equity Partners.
RMC VCM Holdings is a single-deal fund managed by Rock Mountain Capital that solely invests in VCM Products.